LAUSR

1. Niznik JD, Zhao X, He M, et al. Risk for health events after deprescribing acetylcholinesterase inhibitors in nursing home residents with severe dementia. J Am Geriatr Soc. 2020;68(4):699-707. 2. Braillon A. Acetylcholinesterase inhibitors and dementia: over both sides of the Atlantic Ocean. J Am Geriatr Soc. 2020; (in press). 3. Niznik JD, Zhao X, He M, et al. Factors associated with deprescribing acetylcholinesterase inhibitors in older nursing home residents with severe dementia. J Am Geriatr Soc. 2019;67(9):1871-1879. 4. Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58(4): 783-787. 5. Quigley PA, Campbell RR, Bulat T, Olney RL, Buerhaus P, Needleman J. Incidence and cost of serious fall-related injuries in nursing homes. Clin Nurs Res. 2012;21(1):10-23. 6. Berry SD, Lee Y, Zullo AR, Kiel DP, Dosa D, Mor V. Incidence of hip fracture in U.S. nursing homes. J Gerontol A Biol Sci Med Sci. 2016;71(9): 1230-1234.